ecopa 2011 conference & general assembly
December 25, 2010 | Ecopa Events | admin |
Print This Post
Print This Post
10-11 November 2011
Madrid, Spain
Agenda for 10 November – Board Meeting & General Assembly
8:00 Board Meeting 10:30 Coffee Break & Welcome to NCP Representatives 11:00 General Assembly (Board Members & NCP Representatives) 13:30 Lunch 15:00 Elections 17:30 Meeting of New Board Presentations of NCPs at the General Assembly
Programme for 11 November – Annual Conference
9:00 Welcome (ecopa & REMA) 9:15 Alternatives in Upcoming EU Framework Programmes (European Commission, BE) 9:35 SEURAT Project (Maurice Whelan, European Commission JRC, Ispra, IT) 9:55 AXLR8 Project (Troy Seidle, HSI, UK) 10:15 New Advances (Janna de Boer, ZonMW, NL) 10:25 Coffee Break & Poster Session 11:00 Joint CAAT-Europe / ecopa Actions (Thomas Hartung, CAAT, US) 11:20 Inconsistencies in EU Data Requirements (Roman Kolar, DTB/Eurogroup, DE) 11:40 Challenges for the Implementation of Directive 2010/63/EU (Oscar Dignoes, Environment Ministry, ES) 12:00 Round Table 12:30 Lunch 14:00 Coordination of Validation Strategies (Joachim Kreysa, ECVAM, IT) 14:20 The Future of the Validation Process (Manfred Liebsch, ZEBET, DE) 14:40 The Point of View of Industry (Philippe Vanparys, CARDAM, BE) 15:00 The Point of View of the Pharmaceutical Industry (Joan Albert Vericat, Noscira, ES) 15:20 Coffee Break & Poster Session 16:20 Challenges for the 2014 World Congress in Prague (Dagmar Jírová, CZECOPA, CZ) 16:35 Scientific Communications (Selected Posters) & Awards (ecopa & REMA) 17:00 Conclusions & End of Meeting
Latest News & Events
-
New AXLR8 Report: Alternative Testing Strategies – Progress Report 2011
The EU FP7-funded co-ordination project AXLR8 has announced the availability of the publication Alternative Testing Strategies: Progress Report 2011 & ... -
Final START-UP report now available
The final report of the FP7-funded support action START-UP (Scientific and Technological Issues in 3Rs Alternatives Research in The Process ... -
US FDA accepts cell-based potency test for Botox
California-based Allergan, Inc. has had its in-vitro, cell-based assay for testing the stability and potency of Botox and Botox cosmetic, ... -
ECHA releases report on use of non-animal methods & testing strategies under REACH
The European Chemicals Agency has published two major reports on the working of REACH and CLP Regulations and on the ...


